Cargando…

Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome

BACKGROUND: Rett syndrome (RTT) is a pervasive developmental disorder that is progressive and has no effective cure. Immune dysregulation, oxidative stress, and excess glutamate in the brain mediated by glial dysfunction have been implicated in the pathogenesis and worsening of symptoms of RTT. In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nance, Elizabeth, Kambhampati, Siva P., Smith, Elizabeth S., Zhang, Zhi, Zhang, Fan, Singh, Sarabdeep, Johnston, Michael V., Rangaramanujam, Kannan, Blue, Mary E., Kannan, Sujatha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735803/ https://www.ncbi.nlm.nih.gov/pubmed/29258545 http://dx.doi.org/10.1186/s12974-017-1004-5

Ejemplares similares

Correction to: Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome
por: Nance, Elizabeth, et al.
Publicado: (2018)

Scalable synthesis and validation of PAMAM dendrimer‐N‐acetyl cysteine conjugate for potential translation
por: Sharma, Rishi, et al.
Publicado: (2018)

Preferential and Increased Uptake of Hydroxyl-Terminated PAMAM Dendrimers by Activated Microglia in Rabbit Brain Mixed Glial Culture
por: Alnasser, Yossef, et al.
Publicado: (2018)

Microglial migration and interactions with dendrimer nanoparticles are altered in the presence of neuroinflammation
por: Zhang, Fan, et al.
Publicado: (2016)

Systemic administration of dendrimer N‐acetyl cysteine improves outcomes and survival following cardiac arrest
por: Modi, Hiren R., et al.
Publicado: (2021)

Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020)

Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics
por: Sharma, Anjali, et al.
Publicado: (2018)

Dendrimer Brain Uptake and Targeted Therapy for Brain Injury in a Large Animal Model of Hypothermic Circulatory Arrest
por: Mishra, Manoj K., et al.
Publicado: (2014)

Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders
por: Sharma, Anjali, et al.
Publicado: (2020)

Dendrimer-Based N-Acetyl Cysteine Maternal Therapy Ameliorates Placental Inflammation via Maintenance of M1/M2 Macrophage Recruitment
por: Liu, Yang, et al.
Publicado: (2022)

Nanomedicine in cerebral palsy
por: Balakrishnan, Bindu, et al.
Publicado: (2013)

Nanotechnology Approaches for Ocular Drug Delivery
por: Xu, Qingguo, et al.
Publicado: (2013)

Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration
por: Liaw, Kevin, et al.
Publicado: (2020)

Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model
por: Zhang, Zhi, et al.
Publicado: (2020)

Targeted systemic dendrimer delivery of CSF‐1R inhibitor to tumor‐associated macrophages improves outcomes in orthotopic glioblastoma
por: Liaw, Kevin, et al.
Publicado: (2020)

Dendrimer-Conjugated Glutamate Carboxypeptidase II Inhibitor Restores Microglial Changes in a Rabbit Model of Cerebral Palsy
por: Sah, Nirnath, et al.
Publicado: (2023)

Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis
por: Hollinger, Kristen R., et al.
Publicado: (2022)

Systemic Dendrimer-Peptide Therapies for Wet Age-Related Macular Degeneration
por: Wu, Tony, et al.
Publicado: (2023)

Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy
por: Nemeth, Christina L., et al.
Publicado: (2022)

Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice
por: Tallon, Carolyn, et al.
Publicado: (2022)

Galactosylated hydroxyl‐polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning‐induced liver failure
por: Porterfield, Joshua E., et al.
Publicado: (2023)

Dendrimers Target the Ischemic Lesion in Rodent and Primate Models of Nonarteritic Anterior Ischemic Optic Neuropathy
por: Guo, Yan, et al.
Publicado: (2016)

Maternal dendrimer-based therapy for inflammation-induced preterm birth and perinatal brain injury
por: Lei, Jun, et al.
Publicado: (2017)

Acetylation of PAMAM dendrimers for cellular delivery of siRNA
por: Waite, Carolyn L, et al.
Publicado: (2009)

Nanoparticle-based targeting of microglia improves the neural regeneration enhancing effects of immunosuppression in the zebrafish retina
por: Emmerich, Kevin, et al.
Publicado: (2023)

Recent advances in understanding synaptic abnormalities in Rett syndrome
por: Johnston, Michael, et al.
Publicado: (2015)

Microglia activation in a pediatric rabbit model of tuberculous meningitis
por: Tucker, Elizabeth W., et al.
Publicado: (2016)

Engineering clinical translation‐Introduction to Special Issue Dedicated to 2017 Bioengineering and Translational Medicine Conference
por: Kannan, Rangaramanujam M., et al.
Publicado: (2018)

Engineering clinical translation‐Introduction to Special Issue Dedicated to 2017 Bioengineering and Translational Medicine Conference
por: Kannan, Rangaramanujam M., et al.
Publicado: (2018)

Dendrimers for Drug Delivery
por: Chauhan, Abhay Singh
Publicado: (2018)

The Efficacy of N-Acetyl-Cysteine (NAC) Supplementation in FST Model for Screening Antidepressants
por: Memudu, Adejoke Elizabeth
Publicado: (2022)

DNA Condensation by Partially Acetylated Poly(amido amine) Dendrimers: Effects of Dendrimer Charge Density on Complex Formation
por: Yu, Shi, et al.
Publicado: (2013)

Wild type microglia arrest pathology in a mouse model of Rett syndrome
por: Derecki, Noël C., et al.
Publicado: (2012)

Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)

Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
por: Madaan, Kanika, et al.
Publicado: (2014)

N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases
por: Martinez-Banaclocha, Marcos
Publicado: (2022)

Dendrimer Prodrugs
por: da Silva Santos, Soraya, et al.
Publicado: (2016)

Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic
por: Kadam, Shilpa D., et al.
Publicado: (2019)

N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis
por: Ejigu, Dawit A., et al.
Publicado: (2020)

The potential of dendrimer in delivery of therapeutics for dentistry
por: Bapat, Ranjeet A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mcqetmhg4dee2l38hsjhm0b632